Here we used 53BP1 staining to detect residual DNA damage in IR-sensitive and -resistant HNSCC tumors (as shown in Figure 3B) five days after treatment with a single dose of 5 Gy. Here, TP53BP1 is linked to head and neck squamous cell carcinoma.